The drug discovery process undergoes a paradigm shift as ML and AI analyze extensive datasets, accelerating the identification of potential drug candidates and optimizing development timelines.
The drug discovery process undergoes a paradigm shift as ML and AI analyze extensive datasets, accelerating the identification of potential drug candidates and optimizing development timelines. Biomarker discovery benefits from these technologies, aiding in early disease detection and treatment response monitoring.